Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Principal - Investor Relations

ARCHIMED
CompanyARCHIMED
CategoryFinance
LocationNew York
RemoteOn-site (inferred)
EmploymentNot stated
LevelDirector
SalaryNot stated by the employer
Posted24 Apr 2026
Last verified10 Aug 2026
SourceEmployer ATS (workable)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
ABOUT ARCHIMED With offices in Europe, the US and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare. Our mix of operational, medical, scientific and financial expertise positions us as both a strategic and financial partner to healthcare businesses. Priority areas include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools and Biologic Services, MedTech and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its funds, including the largest healthcare-only private equity fund raised by a European-based GP. MED I, MED II and MED Platform I are all top-decile performers for their vintage according to Preqin data. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation. THE TEAM An international team (French, British, German, Polish, Canadian, US, Japanese) with complementary backgrounds across investment, medical, scientific, strategic and operational disciplines. Alumni of INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, École des Ponts ParisTech, ESSEC, Imperial College and Dartmouth, among others. Professional backgrounds spanning Private Equity (3i, Siparex, USS Ltd, Barings, Capiton, Partners Group), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC) and Industry (Biotronik, Cerba, pharmacy and veterinary). THE ROLE Reporting to the Head of Investor Relations and working in close partnership with the firm's Partners and senior leadership, the Principal of Investor Relations will serve as a senior leader of the IR function with shared accountability for the firm's global capital formation strategy and LP franchise. This is a Partner-track role with significant external visibility, senior internal influence and direct responsibility for the growth and institutionalization of ARCHIMED's investor base. The Principal will help shape the forward trajectory of the firm's capital base across flagship funds, co-investment vehicles, GP-led secondaries and new product initiatives, and will act as a primary relationship owner for the firm's most strategic LPs. CAPITAL FORMATION & STRATEGIC LEADERSHIP Partner with the Head of IR and firm leadership to define and execute the firm's multi-year capital formation strategy, including fund architecture, investor segmentation, geographic prioritization and new product development. Hold direct accountability for fundraising outcomes across assigned channels and regions, including pipeline development, LP conversion and commitment sizing against stated targets. Lead the firm's positioning and narrative to the global LP community, ensuring a consistent, differentiated and compelling articulation of strategy, performance, healthcare thesis and impact track record. Own the firm's most strategic LP relationships globally, including sovereign wealth funds, major public pensions, global insurers, top-tier endowments and foundations, and lead consultants. Serve as a trusted senior counterpart to CIOs, heads of PE and investment committees. Identify, cultivate and convert new pools of capital, including untapped geographies, new LP types and new product formats, to support the firm's long-term AUM growth and platform expansion. Serve as a senior external spokesperson for ARCHIMED at major industry conferences, LP advisory boards and public forums, and represent the firm in the most sensitive LP conversations. IR FUNCTION LEADERSHIP Co-lead the IR function alongside the Head of IR, with shared accountability for team structure, talent development, performance management and succession planning across the global IR organization. Set and elevate the standards for LP reporting, communications, servicing and engagement, ensuring the IR platform operates at the level expected by the world's most sophisticated institu